Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Andes

Showing results (51-60 of 207) with videos related to

Pageof 21
Sort By:
Antimicrobial Agents and Chemotherapy|July 11, 2018
<i>In Vivo</i> Pharmacodynamic Characterization of a Novel Odilorhabdin Antibiotic, NOSO-502, against Escherichia coli and Klebsiella pneumoniae in a Murine Thigh Infection ModelMiao Zhao, Alexander J Lepak, Karen Marchillo, et al.
Nanomedicine (London, England)|June 7, 2018
Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activityAnna Jaromin, Robert Zarnowski, Magdalena Piętka-Ottlik, et al.
Eukaryotic Cell|October 13, 2006
Function of Candida albicans adhesin Hwp1 in biofilm formationClarissa J Nobile, Jeniel E Nett, David R Andes, et al.
The Journal of Antimicrobial Chemotherapy|January 6, 2018
We can do better: a fresh look at echinocandin dosingJustin C Bader, Sujata M Bhavnani, David R Andes, et al.
The Journal of Antimicrobial Chemotherapy|January 18, 2018
We can do better: a fresh look at echinocandin dosingJustin C Bader, Sujata M Bhavnani, David R Andes, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2017
<i>In Vivo</i> Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia ModelAlexander J Lepak, Miao Zhao, Karen Marchillo, et al.
Antimicrobial Agents and Chemotherapy|September 5, 2013
Isavuconazole pharmacodynamic target determination for Candida species in an in vivo murine disseminated candidiasis modelAlexander J Lepak, Karen Marchillo, Jamie VanHecker, et al.
JCI Insight|April 23, 2026
In Vivo Characterization of Candida Extracellular Vesicles Reveals Unique Infection Pathway ProteinsJustin Massey, Robert Zarnowski, William Hartman, et al.
Antimicrobial Agents and Chemotherapy|April 19, 2017
<i>In Vivo</i> Pharmacodynamic Target Assessment of Eravacycline against Escherichia coli in a Murine Thigh Infection ModelMiao Zhao, Alexander J Lepak, Karen Marchillo, et al.
Diagnostic Microbiology and Infectious Disease|March 3, 2009
Pharmacokinetic-pharmacodynamic modeling to support doripenem dose regimen optimization for critically ill patientsScott A Van Wart, David R Andes, Paul G Ambrose, et al.
Pageof 21

Showing results (51-60 of 207) with videos related to

Sort By:
Pageof 21
Antimicrobial Agents and Chemotherapy|July 11, 2018
<i>In Vivo</i> Pharmacodynamic Characterization of a Novel Odilorhabdin Antibiotic, NOSO-502, against Escherichia coli and Klebsiella pneumoniae in a Murine Thigh Infection ModelMiao Zhao, Alexander J Lepak, Karen Marchillo, et al.
Nanomedicine (London, England)|June 7, 2018
Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activityAnna Jaromin, Robert Zarnowski, Magdalena Piętka-Ottlik, et al.
Eukaryotic Cell|October 13, 2006
Function of Candida albicans adhesin Hwp1 in biofilm formationClarissa J Nobile, Jeniel E Nett, David R Andes, et al.
The Journal of Antimicrobial Chemotherapy|January 6, 2018
We can do better: a fresh look at echinocandin dosingJustin C Bader, Sujata M Bhavnani, David R Andes, et al.
The Journal of Antimicrobial Chemotherapy|January 18, 2018
We can do better: a fresh look at echinocandin dosingJustin C Bader, Sujata M Bhavnani, David R Andes, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2017
<i>In Vivo</i> Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia ModelAlexander J Lepak, Miao Zhao, Karen Marchillo, et al.
Antimicrobial Agents and Chemotherapy|September 5, 2013
Isavuconazole pharmacodynamic target determination for Candida species in an in vivo murine disseminated candidiasis modelAlexander J Lepak, Karen Marchillo, Jamie VanHecker, et al.
JCI Insight|April 23, 2026
In Vivo Characterization of Candida Extracellular Vesicles Reveals Unique Infection Pathway ProteinsJustin Massey, Robert Zarnowski, William Hartman, et al.
Antimicrobial Agents and Chemotherapy|April 19, 2017
<i>In Vivo</i> Pharmacodynamic Target Assessment of Eravacycline against Escherichia coli in a Murine Thigh Infection ModelMiao Zhao, Alexander J Lepak, Karen Marchillo, et al.
Diagnostic Microbiology and Infectious Disease|March 3, 2009
Pharmacokinetic-pharmacodynamic modeling to support doripenem dose regimen optimization for critically ill patientsScott A Van Wart, David R Andes, Paul G Ambrose, et al.
Pageof 21